Global Vaginal Antifungal Market Growth (Status and Outlook) 2026-2032

May 2026 | 101 pages | ID: G1C308E54B3EEN
LP Information

Abstracts

The global Vaginal Antifungal market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Vaginal Antifungal Industry Forecast” looks at past sales and reviews total world Vaginal Antifungal sales in 2025, providing a comprehensive analysis by region and market sector of projected Vaginal Antifungal sales for 2026 through 2032. With Vaginal Antifungal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaginal Antifungal industry.

This Insight Report provides a comprehensive analysis of the global Vaginal Antifungal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaginal Antifungal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaginal Antifungal market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaginal Antifungal and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaginal Antifungal.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaginal Antifungal market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Fluconazole
• Clotrimazole
• Ketoconazole
• Others

Segmentation by Application:

• Hospital
• Clinic
• Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• ANI Pharmaceuticals
• Lupin
• Unique Pharmaceuticals
• Pfizer
• SCYNEXIS
• Bausch Health Companies
• Hikma Pharmaceuticals
• Pacgen Life Science Corporation
• Astellas Pharma
• Mycovia Pharmaceuticals
• PEPTONIC Medical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vaginal Antifungal Market Size (2021-2032)
  2.1.2 Vaginal Antifungal Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Vaginal Antifungal by Country/Region (2021, 2025 & 2032)
2.2 Vaginal Antifungal Segment by Type
  2.2.1 Fluconazole
  2.2.2 Clotrimazole
  2.2.3 Ketoconazole
  2.2.4 Others
  2.2.5 Vaginal Antifungal Market Size by Type
    2.2.5.1 Vaginal Antifungal Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global Vaginal Antifungal Market Size Market Share by Type (2021-2026)
2.3 Vaginal Antifungal Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Pharmacy
  2.3.4 Vaginal Antifungal Market Size by Application
    2.3.4.1 Vaginal Antifungal Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global Vaginal Antifungal Market Size Market Share by Application (2021-2026)

3 VAGINAL ANTIFUNGAL MARKET SIZE BY PLAYER

3.1 Vaginal Antifungal Market Size Market Share by Player
  3.1.1 Global Vaginal Antifungal Revenue by Player (2021-2026)
  3.1.2 Global Vaginal Antifungal Revenue Market Share by Player (2021-2026)
3.2 Global Vaginal Antifungal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VAGINAL ANTIFUNGAL BY REGION

4.1 Vaginal Antifungal Market Size by Region (2021-2026)
4.2 Global Vaginal Antifungal Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vaginal Antifungal Market Size Growth (2021-2026)
4.4 APAC Vaginal Antifungal Market Size Growth (2021-2026)
4.5 Europe Vaginal Antifungal Market Size Growth (2021-2026)
4.6 Middle East & Africa Vaginal Antifungal Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Vaginal Antifungal Market Size by Country (2021-2026)
5.2 Americas Vaginal Antifungal Market Size by Type (2021-2026)
5.3 Americas Vaginal Antifungal Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vaginal Antifungal Market Size by Region (2021-2026)
6.2 APAC Vaginal Antifungal Market Size by Type (2021-2026)
6.3 APAC Vaginal Antifungal Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Vaginal Antifungal Market Size by Country (2021-2026)
7.2 Europe Vaginal Antifungal Market Size by Type (2021-2026)
7.3 Europe Vaginal Antifungal Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vaginal Antifungal by Region (2021-2026)
8.2 Middle East & Africa Vaginal Antifungal Market Size by Type (2021-2026)
8.3 Middle East & Africa Vaginal Antifungal Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VAGINAL ANTIFUNGAL MARKET FORECAST

10.1 Global Vaginal Antifungal Forecast by Region (2027-2032)
  10.1.1 Global Vaginal Antifungal Forecast by Region (2027-2032)
  10.1.2 Americas Vaginal Antifungal Forecast
  10.1.3 APAC Vaginal Antifungal Forecast
  10.1.4 Europe Vaginal Antifungal Forecast
  10.1.5 Middle East & Africa Vaginal Antifungal Forecast
10.2 Americas Vaginal Antifungal Forecast by Country (2027-2032)
  10.2.1 United States Market Vaginal Antifungal Forecast
  10.2.2 Canada Market Vaginal Antifungal Forecast
  10.2.3 Mexico Market Vaginal Antifungal Forecast
  10.2.4 Brazil Market Vaginal Antifungal Forecast
10.3 APAC Vaginal Antifungal Forecast by Region (2027-2032)
  10.3.1 China Vaginal Antifungal Market Forecast
  10.3.2 Japan Market Vaginal Antifungal Forecast
  10.3.3 Korea Market Vaginal Antifungal Forecast
  10.3.4 Southeast Asia Market Vaginal Antifungal Forecast
  10.3.5 India Market Vaginal Antifungal Forecast
  10.3.6 Australia Market Vaginal Antifungal Forecast
10.4 Europe Vaginal Antifungal Forecast by Country (2027-2032)
  10.4.1 Germany Market Vaginal Antifungal Forecast
  10.4.2 France Market Vaginal Antifungal Forecast
  10.4.3 UK Market Vaginal Antifungal Forecast
  10.4.4 Italy Market Vaginal Antifungal Forecast
  10.4.5 Russia Market Vaginal Antifungal Forecast
10.5 Middle East & Africa Vaginal Antifungal Forecast by Region (2027-2032)
  10.5.1 Egypt Market Vaginal Antifungal Forecast
  10.5.2 South Africa Market Vaginal Antifungal Forecast
  10.5.3 Israel Market Vaginal Antifungal Forecast
  10.5.4 Turkey Market Vaginal Antifungal Forecast
10.6 Global Vaginal Antifungal Forecast by Type (2027-2032)
10.7 Global Vaginal Antifungal Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Vaginal Antifungal Forecast

11 KEY PLAYERS ANALYSIS

11.1 ANI Pharmaceuticals
  11.1.1 ANI Pharmaceuticals Company Information
  11.1.2 ANI Pharmaceuticals Vaginal Antifungal Product Offered
  11.1.3 ANI Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 ANI Pharmaceuticals Main Business Overview
  11.1.5 ANI Pharmaceuticals Latest Developments
11.2 Lupin
  11.2.1 Lupin Company Information
  11.2.2 Lupin Vaginal Antifungal Product Offered
  11.2.3 Lupin Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Lupin Main Business Overview
  11.2.5 Lupin Latest Developments
11.3 Unique Pharmaceuticals
  11.3.1 Unique Pharmaceuticals Company Information
  11.3.2 Unique Pharmaceuticals Vaginal Antifungal Product Offered
  11.3.3 Unique Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Unique Pharmaceuticals Main Business Overview
  11.3.5 Unique Pharmaceuticals Latest Developments
11.4 Pfizer
  11.4.1 Pfizer Company Information
  11.4.2 Pfizer Vaginal Antifungal Product Offered
  11.4.3 Pfizer Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Pfizer Main Business Overview
  11.4.5 Pfizer Latest Developments
11.5 SCYNEXIS
  11.5.1 SCYNEXIS Company Information
  11.5.2 SCYNEXIS Vaginal Antifungal Product Offered
  11.5.3 SCYNEXIS Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 SCYNEXIS Main Business Overview
  11.5.5 SCYNEXIS Latest Developments
11.6 Bausch Health Companies
  11.6.1 Bausch Health Companies Company Information
  11.6.2 Bausch Health Companies Vaginal Antifungal Product Offered
  11.6.3 Bausch Health Companies Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Bausch Health Companies Main Business Overview
  11.6.5 Bausch Health Companies Latest Developments
11.7 Hikma Pharmaceuticals
  11.7.1 Hikma Pharmaceuticals Company Information
  11.7.2 Hikma Pharmaceuticals Vaginal Antifungal Product Offered
  11.7.3 Hikma Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Hikma Pharmaceuticals Main Business Overview
  11.7.5 Hikma Pharmaceuticals Latest Developments
11.8 Pacgen Life Science Corporation
  11.8.1 Pacgen Life Science Corporation Company Information
  11.8.2 Pacgen Life Science Corporation Vaginal Antifungal Product Offered
  11.8.3 Pacgen Life Science Corporation Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Pacgen Life Science Corporation Main Business Overview
  11.8.5 Pacgen Life Science Corporation Latest Developments
11.9 Astellas Pharma
  11.9.1 Astellas Pharma Company Information
  11.9.2 Astellas Pharma Vaginal Antifungal Product Offered
  11.9.3 Astellas Pharma Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Astellas Pharma Main Business Overview
  11.9.5 Astellas Pharma Latest Developments
11.10 Mycovia Pharmaceuticals
  11.10.1 Mycovia Pharmaceuticals Company Information
  11.10.2 Mycovia Pharmaceuticals Vaginal Antifungal Product Offered
  11.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Mycovia Pharmaceuticals Main Business Overview
  11.10.5 Mycovia Pharmaceuticals Latest Developments
11.11 PEPTONIC Medical
  11.11.1 PEPTONIC Medical Company Information
  11.11.2 PEPTONIC Medical Vaginal Antifungal Product Offered
  11.11.3 PEPTONIC Medical Vaginal Antifungal Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 PEPTONIC Medical Main Business Overview
  11.11.5 PEPTONIC Medical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Vaginal Antifungal Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Vaginal Antifungal Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Fluconazole
Table 4. Major Players of Clotrimazole
Table 5. Major Players of Ketoconazole
Table 6. Major Players of Others
Table 7. Vaginal Antifungal Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Vaginal Antifungal Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Vaginal Antifungal Market Size Market Share by Type (2021-2026)
Table 10. Vaginal Antifungal Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Vaginal Antifungal Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Vaginal Antifungal Market Size Market Share by Application (2021-2026)
Table 13. Global Vaginal Antifungal Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Vaginal Antifungal Revenue Market Share by Player (2021-2026)
Table 15. Vaginal Antifungal Key Players Head office and Products Offered
Table 16. Vaginal Antifungal Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Vaginal Antifungal Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Vaginal Antifungal Market Size Market Share by Region (2021-2026)
Table 21. Global Vaginal Antifungal Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Vaginal Antifungal Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Vaginal Antifungal Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Vaginal Antifungal Market Size Market Share by Country (2021-2026)
Table 25. Americas Vaginal Antifungal Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Vaginal Antifungal Market Size Market Share by Type (2021-2026)
Table 27. Americas Vaginal Antifungal Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Vaginal Antifungal Market Size Market Share by Application (2021-2026)
Table 29. APAC Vaginal Antifungal Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Vaginal Antifungal Market Size Market Share by Region (2021-2026)
Table 31. APAC Vaginal Antifungal Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Vaginal Antifungal Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Vaginal Antifungal Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Vaginal Antifungal Market Size Market Share by Country (2021-2026)
Table 35. Europe Vaginal Antifungal Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Vaginal Antifungal Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Vaginal Antifungal Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Vaginal Antifungal Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Vaginal Antifungal Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Vaginal Antifungal
Table 41. Key Market Challenges & Risks of Vaginal Antifungal
Table 42. Key Industry Trends of Vaginal Antifungal
Table 43. Global Vaginal Antifungal Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Vaginal Antifungal Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Vaginal Antifungal Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Vaginal Antifungal Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. ANI Pharmaceuticals Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 48. ANI Pharmaceuticals Vaginal Antifungal Product Offered
Table 49. ANI Pharmaceuticals Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. ANI Pharmaceuticals Main Business
Table 51. ANI Pharmaceuticals Latest Developments
Table 52. Lupin Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 53. Lupin Vaginal Antifungal Product Offered
Table 54. Lupin Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Lupin Main Business
Table 56. Lupin Latest Developments
Table 57. Unique Pharmaceuticals Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 58. Unique Pharmaceuticals Vaginal Antifungal Product Offered
Table 59. Unique Pharmaceuticals Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Unique Pharmaceuticals Main Business
Table 61. Unique Pharmaceuticals Latest Developments
Table 62. Pfizer Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 63. Pfizer Vaginal Antifungal Product Offered
Table 64. Pfizer Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. SCYNEXIS Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 68. SCYNEXIS Vaginal Antifungal Product Offered
Table 69. SCYNEXIS Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. SCYNEXIS Main Business
Table 71. SCYNEXIS Latest Developments
Table 72. Bausch Health Companies Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 73. Bausch Health Companies Vaginal Antifungal Product Offered
Table 74. Bausch Health Companies Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Bausch Health Companies Main Business
Table 76. Bausch Health Companies Latest Developments
Table 77. Hikma Pharmaceuticals Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 78. Hikma Pharmaceuticals Vaginal Antifungal Product Offered
Table 79. Hikma Pharmaceuticals Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Hikma Pharmaceuticals Main Business
Table 81. Hikma Pharmaceuticals Latest Developments
Table 82. Pacgen Life Science Corporation Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 83. Pacgen Life Science Corporation Vaginal Antifungal Product Offered
Table 84. Pacgen Life Science Corporation Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Pacgen Life Science Corporation Main Business
Table 86. Pacgen Life Science Corporation Latest Developments
Table 87. Astellas Pharma Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 88. Astellas Pharma Vaginal Antifungal Product Offered
Table 89. Astellas Pharma Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Astellas Pharma Main Business
Table 91. Astellas Pharma Latest Developments
Table 92. Mycovia Pharmaceuticals Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 93. Mycovia Pharmaceuticals Vaginal Antifungal Product Offered
Table 94. Mycovia Pharmaceuticals Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Mycovia Pharmaceuticals Main Business
Table 96. Mycovia Pharmaceuticals Latest Developments
Table 97. PEPTONIC Medical Details, Company Type, Vaginal Antifungal Area Served and Its Competitors
Table 98. PEPTONIC Medical Vaginal Antifungal Product Offered
Table 99. PEPTONIC Medical Vaginal Antifungal Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. PEPTONIC Medical Main Business
Table 101. PEPTONIC Medical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Vaginal Antifungal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaginal Antifungal Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Vaginal Antifungal Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Vaginal Antifungal Sales Market Share by Country/Region (2025)
Figure 8. Vaginal Antifungal Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Vaginal Antifungal Market Size Market Share by Type in 2025
Figure 10. Vaginal Antifungal in Hospital
Figure 11. Global Vaginal Antifungal Market: Hospital (2021-2026) & ($ millions)
Figure 12. Vaginal Antifungal in Clinic
Figure 13. Global Vaginal Antifungal Market: Clinic (2021-2026) & ($ millions)
Figure 14. Vaginal Antifungal in Pharmacy
Figure 15. Global Vaginal Antifungal Market: Pharmacy (2021-2026) & ($ millions)
Figure 16. Global Vaginal Antifungal Market Size Market Share by Application in 2025
Figure 17. Global Vaginal Antifungal Revenue Market Share by Player in 2025
Figure 18. Global Vaginal Antifungal Market Size Market Share by Region (2021-2026)
Figure 19. Americas Vaginal Antifungal Market Size 2021-2026 ($ millions)
Figure 20. APAC Vaginal Antifungal Market Size 2021-2026 ($ millions)
Figure 21. Europe Vaginal Antifungal Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Vaginal Antifungal Market Size 2021-2026 ($ millions)
Figure 23. Americas Vaginal Antifungal Value Market Share by Country in 2025
Figure 24. United States Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Vaginal Antifungal Market Size Market Share by Region in 2025
Figure 29. APAC Vaginal Antifungal Market Size Market Share by Type (2021-2026)
Figure 30. APAC Vaginal Antifungal Market Size Market Share by Application (2021-2026)
Figure 31. China Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 35. India Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Vaginal Antifungal Market Size Market Share by Country in 2025
Figure 38. Europe Vaginal Antifungal Market Size Market Share by Type (2021-2026)
Figure 39. Europe Vaginal Antifungal Market Size Market Share by Application (2021-2026)
Figure 40. Germany Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 41. France Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Vaginal Antifungal Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Vaginal Antifungal Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Vaginal Antifungal Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Vaginal Antifungal Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 54. APAC Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 55. Europe Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 57. United States Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 58. Canada Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 59. Mexico Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 60. Brazil Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 61. China Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 62. Japan Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 63. Korea Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 65. India Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 66. Australia Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 67. Germany Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 68. France Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 69. UK Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 70. Italy Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 71. Russia Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 72. Egypt Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 73. South Africa Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 74. Israel Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 75. Turkey Vaginal Antifungal Market Size 2027-2032 ($ millions)
Figure 76. Global Vaginal Antifungal Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Vaginal Antifungal Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Vaginal Antifungal Market Size 2027-2032 ($ millions)